Manufacturing and Production

Showing 15 posts of 5866 posts found.

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …

BioNet and BIA Separations collaborate on development of mRNA vaccines

November 2, 2021 Manufacturing and Production

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and Sartorius’ company BIA Separations, have announced the development of an …

Transplant patients to have mandatory full COVID vaccinations at London Health Sciences Centre

November 2, 2021 Manufacturing and Production

The Ontario-based London Health Sciences Centre’s transplant program is implementing a full COVID-19 vaccination requirement for future organ transplant recipients …

Dunad Therapeutics and Novartis enter partnership to develop protein therapies

November 2, 2021 Manufacturing and Production

Biopharmaceutical company Dunad Therapeutics (Dunad) has annouced that it has entered into a strategic collaboration with Novartis, to develop orally …

FDA approve Novartis’ Scemblix to treat leukaemia

November 2, 2021 Manufacturing and Production

Novartis have announced that the FDA approved Scemblix® (asciminib) for the treatment of chronic myeloid leukaemia (CML) in two distinct …

NIHR funds COVID-19 antiviral trial

October 26, 2021 Manufacturing and Production

The National Institute for Health research has awarded funding to the University of Oxford, working with several other UK universities, …

CHMP begins rolling review of COVID oral antiviral

October 26, 2021 Manufacturing and Production

The EMA’s human medicine’s committee (CHMP) has initiated a rolling review of the investigational antiviral drug molnupiravir for the treatment …

Hospitals and pharmacies facing medicine shortages, says The London Economic

October 26, 2021 Manufacturing and Production

As the NHS faces soaring waiting lists and prepares for a winter surge in COVID cases, they must also gear …

MHRA licenses uterine fibroid treatment for women in Great Britain

October 26, 2021 Manufacturing and Production

The MHRA has granted a licence for Ryeqo (a relugolix combination therapy), for the treatment of moderate to severe symptoms …

Hyloris announces approval of new drug for pain management

October 19, 2021 Manufacturing and Production

Specialist biopharma company Hyloris has announced the further extension of the European footprint of Maxigesic® IV, which is a novel …

National Institutes of Health to evaluate Enesi Pharma’s Implavax®-enabled flu vaccines

October 19, 2021 Manufacturing and Production

Enesi Pharma, a pioneering biotechnology company, has entered an agreement with the US National Insitutes of Health’s (NIH) National Institute …

Lipocine and Antares Pharma enter agreement to commercialise TLANDO®

October 19, 2021 Manufacturing and Production

Clinical-stage biopharmaceutical company, Lipocine Inc, has announced that it has entered an exclusive licensing agreement with Antares Pharma Inc to …

Global Heart Hub and Novartis form partnership to combat ASCVD

October 19, 2021 Manufacturing and Production

Global Heart Hub and Novartis have announced the launch of a joint programme to bring together a worldwide network of …
The Gateway to Local Adoption Series

Latest content